Mèra Stein
YOU?
Author Swipe
View article: Fractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel Disease
Fractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel Disease Open
Importance The benefits of fractional flow reserve (FFR)–guided complete coronary revascularization in patients with non–ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease remain unclear. Objective To compare FFR-g…
View article: Long‐term follow‐up of contemporary drug‐eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial
Long‐term follow‐up of contemporary drug‐eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial Open
Objective The elevated risk of adverse events following percutaneous coronary intervention in diabetic patients persists with newer‐generation DES. The polymer‐free amphilimus‐eluting stent (PF‐AES) possesses characteristics with a potenti…
View article: High bleeding risk in patients undergoing percutaneous coronary intervention with drug-eluting stent implantation: ReCre8 subanalysis
High bleeding risk in patients undergoing percutaneous coronary intervention with drug-eluting stent implantation: ReCre8 subanalysis Open
URL: http://www.clinicaltrials.gov, unique identifier: NCT02328898.
View article: Stent length and -diameter and long-term clinical outcomes following percutaneous coronary intervention with drug-eluting stent implantation
Stent length and -diameter and long-term clinical outcomes following percutaneous coronary intervention with drug-eluting stent implantation Open
Background Long total stent length and small stent diameter have been associated with adverse events following percutaneous coronary intervention (PCI). Purpose To assess whether stent length and -diameter influence long-term target-lesion…
View article: Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study
Prevalence of a History of Metabolic or Hypertensive Pregnancy Disorder in Patients With Myocardial Infarction and Non-obstructive Coronary Arteries: An Observational Cohort Study Open
Introduction Myocardial infarction with non-obstructive coronary arteries (MINOCA) predominantly affects younger females. Women with a history of gestational hypertension (GH), preeclampsia (PE), and gestational diabetes mellitus (GDM) are…
View article: Clinical outcomes after permanent polymer or polymer‐free stent implantation in patients with diabetes mellitus: The <scp>ReCre8</scp> diabetes substudy
Clinical outcomes after permanent polymer or polymer‐free stent implantation in patients with diabetes mellitus: The <span>ReCre8</span> diabetes substudy Open
Objectives The purpose of this analysis was to compare target‐lesion failure (TLF) of a permanent polymer zotarolimus‐eluting stent (PP‐ZES) versus a polymer‐free amphilimus‐eluting stent (PF‐AES) in diabetics. Background The improvement o…
View article: Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial
Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial Open
Background Multiple scores have been proposed to guide risk stratification after percutaneous coronary intervention. This study assessed the performance of the PRECISE-DAPT, PARIS and CREDO-Kyoto risk scores to predict post-discharge ischa…
View article: Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial Open
Aims Platelet inhibition induced by P2Y12 receptor antagonists in patients with ST-elevation myocardial infarction (STEMI) can be affected by concomitant use of opioids. The aim of this trial was to examine the effect of intravenous (iv) a…
View article: Long‐term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions
Long‐term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions Open
Objectives The aim was to assess long‐term outcome after deferring intervention of coronary lesions with a fractional flow reserve (FFR) value of >0.80 in a real‐world patient population and then to identify factors associated with deferre…
View article: 96-01: Spatial Heterogeneity of Cx43 and Its Non-phosphorylated Form Is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias in Compensated Cardiac Hypertrophy in Rats
96-01: Spatial Heterogeneity of Cx43 and Its Non-phosphorylated Form Is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias in Compensated Cardiac Hypertrophy in Rats Open
Background: Ventricular hypertrophic remodeling increases the propensity of ventricular tachyarrhythmias and sudden death in patients. We studied the mechanisms underlying these fatal arrhythmias during early compensated hypertrophy in a r…
View article: Spatial Heterogeneity of Cx43 is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias during Compensated Cardiac Hypertrophy in Rats
Spatial Heterogeneity of Cx43 is an Arrhythmogenic Substrate of Polymorphic Ventricular Tachycardias during Compensated Cardiac Hypertrophy in Rats Open
In TAC rats with compensated cardiac hypertrophy, dispersion of conduction correlated to arrhythmogenesis, an increased heterogeneity of Cx43, and a partial substitution with non-phosphorylated Cx43. These alterations may result in the inc…